UK markets close in 6 hours 5 minutes

Traws Pharma Inc (0T2.DU)

Dusseldorf - Dusseldorf Delayed price. Currency in EUR
Add to watchlist
0.3900-0.0100 (-2.50%)
As of 09:30AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
226
226
226
226
231
-
Operating expenses
Research development
9,378
11,430
11,406
7,297
16,898
-
Selling general and administrative
8,504
9,094
8,447
9,425
8,326
-
Total operating expenses
17,882
20,524
19,853
16,722
25,224
-
Operating income or loss
-17,656
-20,298
-19,627
-16,496
-24,993
-
Total other income/expenses net
348
1,350
663
333
-160
-
Income before tax
-17,308
-18,948
-18,964
-16,163
-25,153
-
Income tax expense
-
-
-
0
4
10
Income from continuing operations
-17,308
-18,948
-18,964
-16,163
-25,157
-
Net income
-17,308
-18,948
-18,964
-16,163
-25,157
-
Net income available to common shareholders
-17,308
-18,948
-18,964
-16,163
-25,157
-
Basic EPS
-0.96
-
-0.91
-0.96
-2.17
-335.25
Diluted EPS
-0.96
-
-0.91
-0.96
-2.17
-335.25
Basic average shares
20,967
-
20,908
16,832
11,602
63.932
Diluted average shares
20,967
-
20,908
16,832
11,602
63.932